✦ LIBER ✦

Efficacy and tolerability of a pasteurised human fibrinogen concentrate in patients with congenital fibrinogen deficiency

✍ Scribed by Wolfhart Kreuz; Esther Meili; Kristiina Peter-Salonen; Sabine Haertel; Jan Devay; Udo Krzensk; Rudolf Egbring

Book ID: 116928372
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 110 KB
Volume: 32
Category: Article
ISSN: 1473-0502
DOI: 10.1016/j.transci.2004.08.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and tolerability of human fibri

Efficacy and tolerability of human fibrinogen concentrate administration to patients with acquired fibrinogen deficiency and active or in high-risk severe bleeding

✍ A. Farriols Danés; L. Gallur Cuenca; S. Rodríguez Bueno; L. Mendarte Barrenechea 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

Efficacy and safety of fibrinogen concen

Efficacy and safety of fibrinogen concentrate in trauma patients—a systematic review

✍ Aubron, C.; Reade, M.C.; Fraser, J.F.; Cooper, D.J. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 527 KB

A comparison of fibrinogen measurement m

A comparison of fibrinogen measurement methods with fibrin clot elasticity assessed by thromboelastometry, before and after administration of fibrinogen concentrate in cardiac surgery patients

✍ Cristina Solomon; Janne Cadamuro; Bernhard Ziegler; Herbert Schöchl; Michael Var 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 768 KB

Prophylaxis and therapy with factor VII

Prophylaxis and therapy with factor VII concentrate (human) immuno, vapor heated in patients with congenital factor VII deficiency: A summary of case reports

✍ Lewis J. Cohen; Nancy B. McWilliams; Ronnie Neuberg; William Zinkham; Kenneth Ba 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 754 KB

M.D.P.); and lmmuno A.G., Vienna, Austria (M.K.) Hereditary factor VII deficiency is a rare autosomal recessive condition, usually associated with normal or reduced levels of a functionally defective molecule. The available means of treating thiscondition in North America presents serious health ri

Biochemical Efficacy and Tolerability of

Biochemical Efficacy and Tolerability of a New Augmentation Preparation in Two Patients with MMALTONZ Alpha1-Antitrypsin Deficiency

✍ Stocks, J.M.; Brantly, M. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Interim data on long-term efficacy, safe

Interim data on long-term efficacy, safety and tolerability of a plasma-derived factor VIII concentrate in 109 patients with severe haemophilia A

✍ L. NEMES; H. POLLMANN; T. BECKER 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB